Javara Named Finalist for 2025 SCRS Excellence in Patient Centricity Award

[Winston-Salem, NC — September 2025] – Javara, a leading integrated research organization committed to transforming clinical trials through patient-centered care, is proud to announce it has been named a finalist for the 2025 SCRS Excellence in Patient Centricity Award.

Recognizing Patient-Centered Clinical Research

Presented annually by the Society for Clinical Research Sites (SCRS), the Excellence in Patient Centricity Award recognizes research sites that demonstrate leadership in advancing patient-centric clinical trials, prioritizing accessibility, inclusion, and innovation to improve the patient experience.

About the SCRS Site Excellence Awards

The 2025 SCRS Site Excellence Awards will celebrate organizations that are driving progress across clinical research through innovation, patient inclusion, and site network collaboration. Javara is proud to stand alongside other leading site networks and research organizations shaping the future of clinical trials.

Winners will be announced at the 2025 Global Site Solutions Summit, hosted by SCRS in Orlando on September 30th.

About Javara

As a leading Integrated Research Organization (IRO), we partner with major healthcare systems to embed clinical trials at the point of care, connecting patients to research through physicians they already trust, in the communities they already love. Our model unlocks access to broader, more diverse populations, driving faster enrollment, stronger retention, and richer data. With centralized resources and streamlined operations, we accelerate study start-up and reduce friction across the research lifecycle. Javara drove the evolution of Clinical Research as a Care Option (CRAACO) because we believe research should be accessible, inclusive, and seamlessly integrated into healthcare. Today, we’re delivering on that vision, plus so much more.

Research, integrated. Healthcare, elevated. For more information, visit javararesearch.com and follow the company on LinkedIn.